Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers

Pharmaceutical Research

Volumn 16, Issue 3, 1999, Pages 396-401

  Miller, Donald W ^a   Batrakova, Elena V ^a   Kabanov, Alexander V ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Block copolymer; Cancer; Multidrug resistance; Pluronic

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; COPOLYMER; FLUORESCEIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; POLOXAMER;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; DRUG ELIMINATION; DRUG TRANSPORT; EFFUSION; HUMAN; HUMAN CELL; MONOLAYER CULTURE; MULTIDRUG RESISTANCE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0032929216     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018873702411     Document Type: Article

References (30)

1. 1. A. Krishan, C. M. Fitz, and I. Andritsch. Drug retention, efflux, and resistance in tumor cells. Cytometry 29:279-285 (1997).
2. 2. H. W. Van Veen and W. N. Konings. Multidrug transport from bacteria to man: similarities in structure and function. Semin. Cancer Biol. 8:183-191 (1997).
3. 3. P. G. Bray and S. A. Ward. A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in plasmodium falciparum. Pharmacol. Ther. 77:1-28 (1998).
4. 4. U. A. Germann, I. Pastan, and M. M. Gottesman. p-Glycoproteins: mediators of multidrug resistance. Semin. Cell. Biol. 4:63-76 (1993).
5. 5. A. H. Schinkel, J. J. M. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. J. te Riele, A. J. M. Berns, and P. Borst. Disruption of the mouse mdr-1 a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502 (1994).
6. 6. V. Y. Alakhov, E. Y. Moskaleva, E. V. Batrakova, and A. V. Kabanov. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjugate Chem. 7:209-216 (1996).
7. 7. A. Venne, S. Li, R. Mandeville, A. V. Kabanov, and V. Y. Alakhov. Hypersensitizing effect of pluronic L6I on cytotoxic activity, transport and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res. 56:3626-3629 (1996).
8. 8. D. W. Miller, E. V. Batrakova, T. O. Waltner, V. Y. Alakhov, and A. V. Kabanov. Interactions of Pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. Bioconjugate Chem. 8:649-657 (1997).
9. 9. M. A. Barrand, T. Bagrij, and S. Y. Neo. Multidrug resistance-associated protein: a protein disinct from P-glycoprotein involved in cytotoxic drug expulsion. Gen. Pharmacol. 28:639-645 (1997).
10. 10. Z. Hollo, L. Homolya, T. Hegedus, and B. Sarkadi. Transport properties of the multidrug resistance-associated protein (MRP) in human tumor cells. FEBS Lett. 383, 99-104 (1996).
11. 11. G. Jedlitschky, I. Leier, U. Buchholz, K. Barnouin, G. Kurz, and D. Keppler. Transport of glutatione, glucuronate, and sulfate conjugates by the MRP gene-encoded export pump. Cancer Res. 56:988-994 (1996).
12. 12. M. J. Flens, G. J. Zaman, P. van-der-Valk, M. A. Izquierdo, A. B. Schroeijers, G. L. Scheffer, P. van-der-Groep, M. de-Haas, C. J. Meijer, R. J. Scheper. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148:1237-1247 (1996).
13. 13. D. W. Miller, M. Fontaine, C. Kolar, T. Lawson. The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. Cancer Lett. 107:301-306 (1996).
14. 14. H. Huai-Yun, D. T. Secrest, K. S. Mark, D. Carney, C. Brandquist, W. F. Elmquist, and D. W. Miller. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem. Biophys. Res. Com. 243: 816-820 (1998).
15. 15. M. P. Draper, R. L. Martell, and S. B. Levy. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. Br. J. Cancer 75:810-815 (1997).
16. 16. M. Fontaine, W. F. Elmquist, and D. W. Miller. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. Life Sci. 59:1521-1531 (1996).
17. 17. E. V. Batrakova, H.-Y. Han, V. Yu. Alakhov, D. W. Miller, and A. V. Kabanov. Effects of Pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res. 15:850-855 (1998).
18. 18. K. Nooter and G. Stoter. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol. Res. Pract. 192:768-780 (1996).
19. 19. L. M. Breuninger, S. Paul, K. Gaughan, T. Miki, A. Chan, S. A. Aaronson, and G. D. Kruh. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer. Res. 55:5342-5347 (1995).
20. 20. I. Cleary, G. Doherty, E. Moran, and M. Clynes. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem. Pharmacol. 53:1493-1502 (1997).
21. 21. P. R. Twentyman. Transport proteins in drug resistance: biology and approaches to circumvention. J. Intern. Med. Suppl. 740:133-137 (1997).
22. 22. A. B. Shapiro, K. Fox, P. Lee, Y. D. Yang, and V. F. Ling. Functional intracellular P-glycoprotein. Int. J. Cancer 76:857-864 (1998).
23. 23. Y. Abe, Y. Ohnishi, M. Yoshimura, E. Ota, Y. Ozeki, Y. Oshika, T. Tokunaga, H. Yamazaki, Y. Ueyema, T. Ogata, N. Tamaoki, and M. Nakamura. P-Glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. Br. J. Cancer 74:1929-1934 (1996).
24. 24. G. D. Kruh, K. T. Gaughan, A. Godwin, and A. Chan. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J. Natl. Cancer Inst. 87:1256-1258 (1995).
25. 25. M. J. Flens, G. J. Zaman, P. van der Valk, M. A. Izquierdo, A. B. Schroeijers, G. L. Scheffer, P. van der Groep, M. de Haas, C. J. Meijer, and R. J. Scheper. Tissue distribution of the multidrug resistance protein. Am. J. Phathol. 148:1237-1247 (1996).
26. 26. B. D. Stride, G. Valdimarsson, J. H. Gerlach, G. M. Wilson, S. P. Cole, and R. G. Deeley. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. Mol. Pharmacol. 49:962-971 (1996).
27. 27. E. V. Batrakova, T. Yu. Dorodnych, E. Yu. Klinskii, E. N. Kliush-nenkova, O. B. Shemchukova, S. A. Arjakov, V. Yu. Alakhov, A. V. Kabanov. Anthracycline antibiotics non-covalently incorporated into the block-copolymer micelles: in vivo evaluation of anticancer activity. Br. J. Cancer 74:1545-1552 (1996).
28. 28. V. Yu. Alakhov, A. V. Kabanov. Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Op. Invest. Drugs 7:1453-1473 (1998).
29. 29. E. V. Batrakova, H -Y. Man, D. W. Miller, A. V. Kabanov. Effects of Pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm. Res. 15:1525-1532 (1998).
30. 30. R. B. Kim, M. F. Fromm, C. Wandel, B. Leake, A. J. J. Wood, D. M. Roden, and G. R. Wilkinson. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest. 101:289-294 (1998).